Intramural AIDS Research Fellowship (IARF) 2026: NIH Intramural Fellowship for HIV/AIDS Early-Career Scientists

Captured cycle: This page is retained for historical guidance. Confirm whether the program has reopened before planning an application.

Intramural AIDS Research Fellowship (IARF) 2026: NIH Intramural Fellowship for HIV/AIDS Early-Career Scientists

The Intramural AIDS Research Fellowship (IARF) is an NIH internal funding and training path for graduate and postdoctoral trainees who want to do HIV/AIDS work inside NIH over a defined short cycle. It is a joint initiative from the Office of AIDS Research, Office of Intramural Training & Education, and Office of Intramural Research.

The program is unusual in three ways: it is specific to HIV and AIDS-related research, it is explicitly tied to mentorship quality, and it is designed to be a one-year supported fellowship with a possible second year.

The page indicates the 2026 application opens Monday, April 13, 2026 and closes at 5:00 p.m. EDT on Wednesday, May 13, 2026. Awards are expected in early June. If your goal is a high-quality, NIH-based research training cycle tied directly to an identified mentor and lab context, this is worth serious consideration.

At a glance

What the fellowship is (and what it is not)

IARF is a short, structured NIH intramural fellowship model focused on HIV/AIDS research breadth. NIH lists candidate-appropriate research domains broadly, including epidemiology, therapeutics, pathogenesis, vaccine science, implementation science, behavioral and social research, and related complications from HIV infection.

This is not a broad external grant process with a centralized federal portal like grants.gov or Research.gov. It is also not primarily a PI-led research group grant where only one person is responsible for institutional approvals. It is designed around the individual fellow, their mentor, and alignment with an NIH research training trajectory.

The page and PDF describe the program as recruiting new talent into HIV/AIDS research inside NIH. In practical terms, success tends to come from this sequence:

1. You already have a viable, scientifically coherent one-year project idea linked to HIV/AIDS outcomes.
2. You can show this project is feasible within one year.
3. You can show a concrete training plan, not just an experiment list.
4. Your mentor provides concrete commitment and a clear path to skill development.

When these four conditions are not jointly present, candidates usually fall short even when their science is strong.

Why this is a strong fit for some trainees

The first screening question for fit is whether your position is eligible in structure, not just in topic.

• If you are already inside NIH as an eligible graduate or postdoctoral trainee pathway, this is potentially the best match.
• If you are an external student with no NIH intramural affiliation, this is usually not the right match.
• If your objective is to fund a long, multi-year postdoc beyond two years at NIH, this fellowship may not be enough by itself.

The program is also practical for people who want an explicit career development framing in addition to technical work. A lot of NIH training opportunities are research-heavy and less prescriptive about personal development language. IARF explicitly asks for career planning in its core package.

NIH publishes that renewal applications from 2025 fellows are considered and that all application material must be complete for renewal as well. It also expects major updating of CV and development plans, which means this is a progression program, not a copy-paste resubmission.

Who can apply, and who cannot

Here are the critical eligibility points as currently published.

• Eligible applicants include:
  • NIH Graduate Partnerships Program graduate (predoctoral) trainees.
  • NIH Intramural Research Program postdoctoral trainees in specific tracks: IRTAs, CRTAs, Visiting Fellows.
  • Both U.S. citizens and international applicants.
• Not eligible:
  • Research and Clinical Fellows.
  • Other appointment types that are not listed in the eligible trainee categories (for example, other FTE roles).

This means the eligibility filter is mostly position-based, not only subject-based.

Important: there is no citizenship restriction, which is uncommon compared with many federal fellowships. This widens access but does not change the requirement that applicants must be in the exact NIH categories listed.

What you must submit

NIH gives an unusually explicit submission structure. The page and call-for-applications PDF both define materials that go in a single PDF package.

1) Cover page

Must include:

• project title
• applicant name and title
• mentor name and title
• sponsoring institute or center
• proposed start date
• signatures from proposed mentor and scientific director (or designee)

The objective is to establish legal/project ownership and confirm institutional oversight early.

2) Curriculum vitae (CV)

• Max 3 pages.
• No NIH biosketch format.
• Should show productivity (publications, posters, talks, patents).
• Should show career skill-building actions.
• Should show mentoring or outreach contributions.

This is one of the strongest screening points in practice. A strong CV for IARF is not only research output; it is trajectory and potential.

3) Research plan

• Max 4 pages, single-spaced, including references.
• Minimum font size 10.
• Must include realistic, clear aims.
• Must show scientific novelty.
• Must directly support HIV/AIDS advancement.
• Must be feasible in one fellowship year.

Since review is equal across all components, this component cannot be technically weak and then compensated elsewhere.

4) Relationship to NIH HIV Strategic Plan

NIH allows this to be part of your research plan or a short separate section (or document up to half a page).

The key is direct mapping to current NIH HIV priorities, not generic references. Use specific language and avoid broad claims.

5) Career development plan

• Max 2 pages, double-spaced.
• Must clearly state your stage and goals.
• Must specify training goals and methods.
• Should include workshop/training activities and what each contributes.
• Must show how this year of work changes your career trajectory.
• Must be feasible in one year.

For this program, career development is not optional framing; it is a scored component.

6) Letter of support

From proposed mentor only. Must cover applicant goals, mentorship history, resources, and support of the candidate’s career path.

A common error is treating this as ceremonial copy. NIH explicitly expects this letter to show evidence of mentorship capacity.

Submission workflow and mechanics

Unlike portal-based fellowships, IARF uses an email-based submission route. As published, submissions are made to Dr. Gail Seabold at [email protected] with a specific subject line format: IARF 2026_Last Name, First Name, IC.

Because this is email delivery, technical compliance can be just as important as scientific quality.

Recommended workflow:

1. Build all required sections in separate files with stable filenames.
2. Merge into one PDF with exact page limits.
3. Confirm mentor and IC director signatures before final assembly.
4. Confirm that your career plan and research plan both claim the same project timeline.
5. Confirm no prohibited format like NIH biosketch for CV.
6. Confirm submission subject line and file naming.
7. Send once, and keep sent confirmation and timestamp evidence.

The PDF call document frames submission as one electronic package. If you split documents and they do not merge cleanly into one submission or lose signatures, this can create avoidable rejection risk.

Timeline and practical calendar

The currently published dates are simple and short:

• April 13, 2026: application opens.
• May 13, 2026 at 5:00 p.m. EDT: submission deadline.
• Early June 2026: awards announced.
• Renewal window: only for current 2025 fellows, with complete annual materials.

This timeline means that the project, plan, and mentor alignment should be finalized fast. A practical timeline for teams often looks like:

• Week 1–2 after opening: finalize topic and confirm mentor participation.
• Week 3–4: produce draft research and career development plans.
• Week 5–6: refine CV evidence against stated strengths.
• Week 7: request formal signatures and finalize narrative.
• Week 8: merge package and submit early where possible.

In short, do not wait to the final day of May 13, because formatting and mentor logistics can consume all remaining time.

Review criteria, with practical interpretation

NIH states it gives equal emphasis to five areas:

1. Candidate quality based on CV
2. Career development plan
3. Research proposal
4. Mentor quality and support
5. Relationship to NIH HIV Strategic Plan

The practical implication is straightforward: a weak piece in any one area reduces the competitiveness of the entire package.

Why this is important:

• A polished research idea can fail if career development is generic.
• Strong career intent can fail if the mentor letter does not document real mentorship support.
• Good methods can fail if alignment to HIV priorities is vague.

For applicants in cross-disciplinary science, this is actually an advantage. If your primary question is biomedical and your mentor context is strong, you can compensate for field novelty if training and strategic fit are convincing.

Common mistakes (and why reviewers treat them seriously)

1. Treating the package as a standard NIH fellowship without strategic alignment

Some applicants submit a technically strong idea but skip explicit HIV strategic alignment. Since this is an AIDS-focused pathway, that omission is often a hidden disqualifier.

2. Ignoring the career-development scoring weight

This is a frequent trap because many applicants focus almost entirely on science and not on progression design. Reviewers explicitly balance science and career development.

3. Using the wrong CV format

NIH instructs explicitly not to use an NIH biosketch format for the CV component. That requirement is easy to miss and can create compliance issues.

4. Late signatures or missing approvals

The cover-page signoff requirement is not clerical. It verifies that the proposed submission is authorized by the mentor and scientific leadership.

5. Overly ambitious one-year plans

Research plans that cannot be completed in one year are frequently marked down for feasibility. This is especially relevant for bench-heavy or clinical-research concepts that need long data acquisition windows.

6. Assuming all intramural fellows can apply automatically

Eligibility is specific to named trainee categories. Even within NIH, not all appointments are accepted.

Renewal and 2026-to-2027 pathway

Because the call allows a second-year award and states no individual gets more than two years, planning for Year 2 starts during Year 1.

A renewal is not treated as a simple extension. NIH expects a full package again, with a significantly updated career plan and CV. For 2026 fellows, a good Year 2 strategy should already include:

• Evidence of progress against Year 1 aims.
• A clear updated research plan for second-year work.
• Documented skills gained and remaining gaps.
• Continued mentor endorsement that reflects actual development.

The practical planning signal is this: if your Year 1 output is thin but your Year 2 goals are strong, reviewers may still prefer a clean one-year completion and pause.

From a 2026–2027 planning perspective, this is still a relevant opportunity because the same 2026 cohort can transition into renewal cycles that run into the following year if approved.

FAQ

Is this open only to U.S. citizens?

No. The published eligibility does not impose citizenship restriction for this fellowship.

What is the total value per applicant?

The published documents state Year 1 stipend support and health insurance at $80,000. The program may fund a second year, making an applicant’s total support potentially reach two years, depending on availability and review outcomes.

Is the 2026 package still valid for 2027?

The published page is for the 2026 cycle with a 2026 deadline. Renewal applications are possible for existing 2025 fellows and are still tied to the review framework. That does create a 2027 planning context, but each annual cycle should still be verified directly at the official source.

Do grant-funded external applications replace this fellowship process?

No. This is a separate NIH intramural training opportunity with its own documents, package format, and submission route.

Can I submit multiple drafts?

You can prepare drafts, but NIH requires a complete final package at submission. There is no replacement for a complete, signed package meeting all five review areas.

Strategic fit checklist

Use this as a quick internal filter before committing resources:

• Are you an eligible NIH GP or IRP trainee (IRTA, CTRA, Visiting Fellow)?
• Can you complete a 1-year HIV research project with clear feasibility?
• Do you have a mentor committed to this specific application?
• Can you produce a 2-page career development plan with concrete activities?
• Can you complete all sections with proper formatting and signatures before May 13?

If most answers are yes, IARF is a real option, not a nice-to-have.

Why it is still a 2026/2027-relevant option

The opportunity is listed as 2026 and has a fixed 2026 call deadline, but because renewals may continue into a second year, preparation and planning can extend across the 2026–2027 window. For candidates who need short-cycle NIH-supported intramural funding tied to HIV and AIDS research, this can be a practical bridge between training and independent direction.

Official links and primary sources

• Official IARF page: https://www.training.nih.gov/fellowship-awards/intramural-aids-research-fellowship/
• 2026 call-for-applications PDF: https://www.training.nih.gov/documents/126/IARF_2026_CALL_FOR_APPLICATIONS_1.pdf
• OITE CV formatting support and related development resources linked from the page.